p53 expression in human carcinomas: Could flow cytometry be an alternative to immunohistochemistry?

Journal of Histochemistry and Cytochemistry

Volumn 46, Issue 1, 1998, Pages 41-47

  Benini, Elvira ^a   Costa, Aurora ^a   Abolafio, Gabriella ^a   Silvestrini, Rosella ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Flow cytometry; Human tumors; Immunohistochemistry; P53 expression

Indexed keywords

PROTEIN P53;

ARTICLE; BREAST CARCINOMA; CARCINOMA; CELL CYCLE; COLON CARCINOMA; FLOW CYTOMETRY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 0031985040     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1177/002215549804600106     Document Type: Article

References (24)

1. Agrawal RS, Agrawal YP, Mäntyjärvi RA (1994) Flow cytometric quantitation of c-myc and p53 proteins in bovine papilloma-virus type 1-transformed primary mouse fibroblasts. Cytometry 17:237-245
2. Altman DG, Bland JM (1983) Measurement in medicine: the analysis of method comparison studies. Statistician 32:307-317
3. Blondal JA, Benchimol S (1994) The role of p53 in tumor progression. Cancer Biol 5:177-186
4. Blount PL, Ramel S, Raskind WH, Haggitt RC, Sanchez CA, Dean PJ, Rabinovitch PS, Reid BJ (1991) 17p allelic deletions and p53 protein overexpression in Barren's adenocarcinoma. Cancer Res 51:5482-5486
5. Camplejohn RS (1994) The measurement of intracellular antigens and DNA by multiparametric flow cytometry. J Microsc 176:1-7
6. Clark JS, George WD, Campbell AM (1992) Dual colour flow cytometry of p53 and c-erbB-2 expression related to DNA aneuploidy in primary and metastatic breast cancer. Cancer Lett 66:193-200
7. Danova M, Giordano M, Mazzini G, Riccardi A (1990) Expression of p53 protein during the cell cycle measured by flow cytometry in human leukemia. Leukemia Res 14:417-422
8. Fan S, El-Deiry WS, Bae I, Freeman J, Jondle D, Bhatia K, Fornace AJ, Magrath I, Kohn KW, O'Connor PM (1994) P53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res 54: 5824-5830
9. Gazitt Y, Erdos GW (1994) Fluctuations and ultrastructural localization of oncoproteins and cell cycle regulatory proteins during growth and apoptosis of synchronized AGF cells. Cancer Res 54: 950-956
10. Goukon Y, Sasano H, Nishihira T, Nagura H, Mori S (1994) p53 overexpression in human esophageal carcinoma: a correlation with tumor DNA ploidy and two parameter flow cytometric study. Anticancer Res 14:1305-1312
11. Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878
12. Hall PA, Lane DP (1994) P53 in tumour pathology: can we trust immunohistochemistry? - revisited! J Pathol 172:1-4
13. Harris CC, Hollstein M (1993) Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 329:1318-1327
14. Hickman AW, Jaramillo RJ, Lechner JF, Johnson NF (1994) α-particle-induced p53 protein expression in a rat lung epithelial cell strain. Cancer Res 54:5797-5800
15. Mørkve O, Halvorsen OJ, Skjaerven R, Stangeland L, Gulsvik A, Laerum OD (1993) Prognostic significance of p53 protein expression and DNA ploidy in surgically treated non-small cell lung carcinomas. Anticancer Res 13:571-578
16. Mørkve O, Halvorsen OJ, Stangeland L, Gulsvik A, Laerum OD (1992) Quantitation of biological tumor markers (p53, c-myc, Ki-67 and DNA ploidy) by multiparameter flow cytometry in non-small-cell lung cancer. Int J Cancer 52:851-855
17. Porter PL, Gown AM, Kramp SG, Coltrera MD (1992) Widespread p53 overexpression in human malignant tumors. Am J Pathol 140:145-153
18. Qiao L, Wu P, Ghaleb AH, Pizzolo JG, Miller TB, Melamed MR (1994) Bivariate flow cytometric analysis of p53 and DNA content in hepatocellular carcinoma. Anal Quant Cytol Histol 16:124-130
19. Ramel S, Reid BJ, Sanchez CA, Blount PL, Levine DS, Neshat K, Haggitt RC, Dean PJ, Thor K, Rabinovitch PS (1992) Evaluation of p53 protein expression in Barren's esophagus by two-parameter flow cytometry. Gastroenterology 102:1220-1228
20. Remvikos Y, Tominaga O, Hammel P, Laurent-Puig P, Salmon RJ, Dutrillaux B, Thomas G (1992) Increased p53 protein content of colorectal tumours correlates with poor survival. Br J Cancer 66:758-764
21. Sharma S, Schwarte-Waldhoff I, Oberhuber H, Schäfer R (1993) Functional interaction of wild-type and mutant p53 transfected into human tumor cell lines carrying activated RAS genes. Cell Growth Differ 4:861-869
22. Silvestrini R, Benini E, Daidone MG, Veneroni S, Boracchi P, Cappelletti V, Di Fronzo G, Veronesi U (1993) P53 as an independent prognostic marker in lymph node-negative breast cancer patients. J Natl Cancer Inst 85:965-970
23. Soussi T, Legros Y, Lubin R, Ory K, Schlichtholz B (1994) Multifactorial analysis of p53 alteration in human cancer: a review. Int J Cancer 57:1-9
24. Zhu YM, Bradbury D, Russell LN (1993) Expression of different conformations of p53 in the blast cells of acute myeloblastic leukaemia is related to in vitro growth characteristics. Br J Cancer 68:851-855